Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001401914-25-000037
Filing Date
2025-07-10
Accepted
2025-07-10 16:05:27
Documents
1
Period of Report
2025-07-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1752177920.html 4  
1 FORM 4 wk-form4_1752177920.xml 4 4009
  Complete submission text file 0001401914-25-000037.txt   5692
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Issuer) CIK: 0001401914 (see all company filings)

EIN.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O DARE BIOSCIENCE, INC. 11119 NORTH TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037
Business Address
Grossman Jessica D. (Reporting) CIK: 0001736781 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36395 | Film No.: 251116387